The editors of Chain Drug Review have named the employees of Walgreen Co. — and more particularly, five of the company’s top executives — as the publication’s 2011 Chain Drug Retailers of the Year.
Absent the last-minute shopping surge that rescued holiday sales a year ago, Christmas 2011 was in the main a dismal event for the nation’s drug chains. The holiday shopping season that began on Black Friday, Nov. 25, and ended 30 days later on Christmas Eve — giving the retail community one more
Mylan Inc. has announced the rollout of two new generic drugs, including medications for high blood pressure and epilepsy. The company said Tuesday that its subsidiary Mylan Pharmaceuticals Inc.
Perrigo Co. has gained final approval from the Food and Drug Administration for desloratadine tablets (5 mg), an allergy medication.
Walgreen Co.’s new "health and daily living store" concept has made its debut in Washington, D.C., and the drug chain plans more of the new-format stores in that market.
In a setback for Canadian drug store chains, the Ontario government has won an appeal to reinstate a ban on private-label generic drugs in the province.
Retail pharmacy teams, including pharmacy technicians, are offering practical solutions to patients about how to best use remaining 2011 flexible spending account (FSA) funds, according to the Pharmacy Technician Certification Board (PTCB).
CutisPharma Inc. has extended its FIRST Magic Mouthwash line with four- and six-ounce BLM compounding kits.
Amneal Pharmaceuticals has launched what it said is the first generic Felbamate oral suspension in 600 mg/5 ml strength. Amneal said Wednesday that the first-to-market product is an AB-rated, therapeutically equivalent alternative to Meda Pharmaceuticals’ Felbatol.
With no resolution imminent in its stand-off with Express Scripts Inc., Walgreen Co. said it’s prepared to take a short-term hit rather than digest the long-term consequences of accepting the pharmacy benefit manager’s contract proposal.
MinuteClinic has entered into a clinical collaboration with UMass Memorial Health Care, the largest health care system in central and western Massachusetts and the clinical partner of the University of Massachusetts Medical School.
PuraMed BioScience Inc. is hatching plans for the national product launch of LipiGesic M, its clinically tested migraine headache treatment.
Medco Health Solutions Inc. shareholders have approved the company’s proposed merger with Express Scripts Inc.
Net earnings slipped at Walgreen Co. in its fiscal 2012 first quarter as the drug chain cited its contract impasse with Express Scripts Inc., a slow cough/cold and flu season, and a tough year-over-year comparison as impacting results. Walgreens said Wednesday that for the first quarter ended Nov.
Prestige Brands Holdings Inc. plans to acquire 17 over-the-counter pharmaceutical brands sold in North America from GlaxoSmithKline in $660 million cash deal.
Amgen and Watson Pharmaceuticals Inc. plan to collaborate on the development and global commercialization of several oncology antibody biosimilar medicines.
